Horizontal healthcare utilization inequity in patients with rare diseases in Korea

Springer Science and Business Media LLC
Daewon Kang1, Sang-Eun Choi1
1College of Pharmacy, Korea University, 2511, Sejongro, Sejong, South Korea

Tóm tắt

Abstract Background Rare diseases (RDs) are difficult to diagnose and expensive to treat. Thus, the South Korean government has implemented several policies to help RD patients, including the Medical Expense Support Project, supporting low- to middle-income RD patients. However, no study in Korea has yet addressed health inequity in RD patients. This study assessed inequity trends in the medical utilization and expenditures of RD patients. Methods This study measured the horizontal inequity index (HI) of RD patients and an age- and sex-matched control group using the National Health Insurance Service data from 2006 to 2018. Sex, age, number of chronic diseases, and disability variables were used to model expected medical needs and adjust the concentration index (CI) for medical utilization and expenditures. Results The HI index of healthcare utilization in RD patients and the control group ranged from -0.0129 to 0.0145, increasing until 2012 and fluctuating since then. This increasing trend was more apparent for inpatient utilization in the RD patient group than in the outpatient group. The same index in the control group ranged from -0.0112 to -0.0040 without a significant trend. The healthcare expenditure HI in RD patients rose from -0.0640 to -0.0038, showing pro-poor values but moving toward a pro-rich state. In the control group, the HI for healthcare expenditures remained between 0.0029 and 0.0085. Conclusions The HI of inpatient utilization and inpatient expenditures increased in a pro-rich state. The study results showed that implementing a policy that supports inpatient service utilization could help achieve health equity for RD patients.

Từ khóa


Tài liệu tham khảo

Orphan Drug Act Public Law 97-414. 97th Congress. US. 1983. p. 2049–66. Available online at: https://www.fda.gov/media/99546/download. 

European Parliament, Council of the European Union. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Official J Eur Communities. 2000;L018(43):1–6.

Choi EK, Lee JW. Main results of statistical yearbook of rare diseases. Public Health Weekly Rep PHWR. 2021;14(28):2025–36.

Meng Q, Li R, Cheng G, Blas E. Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China. Int J Health Plann Manage. 2004;19(1):5-S62.

Song YJ. The South Korean health care system. JAMAJ. 2009;3:206–9.

Jang SI. The improvement strategy and causes of the patients’ concentrations on large hospitals. Korean Soc Public Health Med. 2019;3:165–9.

Ministry of Health and Welfare. Health and welfare statistical yearbook 2022. Sejong: Ministry of Health and Welfare; 2022.

Moon SH. Equity in the finance and delivery of health care. Korean Soc Secur Stud. 2004;20(1):59–81.

Kim YJ, Lee WK, Kam S. Inequity trend on medical utilization by diseases. J Health Inform Stat. 2018;43(2):223–30.

Kim JG. Income-related Inequality of Health Care Utilization in Korea, 2009–2015. Korean Soc Secur Stud. 2019;35(2):63–92.

Kim DJ, Youn HM, Lee JA, Chae HR. Measurement of Inequalities in Health Care Utilization in Korea Using Korea Health Panel. Health Soc Welfare Rev. 2014;34(3):33–58.

Wagstaff A, van Doorslaer E, Paci P. On the measurement of horizontal inequity in the delivery of health care. J Health Econ. 1991;10(2):169–205.

Kakwani NC. Measurement of tax progressivity: an international comparison. Econ J. 1977;87:71–80.

Wagstaff A, Paci P, van Doorslaer E. On the measurement of inequalities in health. Soc Sci Med. 1991;33(5):545–57.

O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation. World Bank Institute; Washington, D.C: 2008.

Nahm J. An exploratory study on the measurement of equity in contribution system of national health insurance: focused on the application of palma ratio. Health Soc Welfare Rev. 2014;34(4):036–67.

Kwon SM, Yang BM, Lee TJ, Oh JW, Lee SH. Equity in health care utilization in Korea. Korean Health Econ Assoc. 2003;9(2):13–23.

Kim DJ, Kim JE, Park EJ, Shin HS. Study on horizontal inequity in health care utilization in Korea. Sejong: Korea Institute for Health and Social Affairs; 2011.

O’Donnell OA, Wagstaff A. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington, DC: World Bank Publications; 2008.

National Health Insurance Services. Disease Statistics Service by Theme. Available at: https://nhiss.nhis.or.kr/bd/ad/bdada004cv.do. Accessed 23 Dec 2021.

Culyer AJ, Wagstaff A. Equity and equality in health and health care. J Health Econ. 1993;12(4):431–57.

Ev D, Koolman X, Jones AM. Explaining income related inequalities in doctor utilization in Europe. Health Econ. 2004;13(7):629–47.

Bleichrodt H, Van Doorslaer E. A welfare economics foundation for health inequality measurement. J Health Econ. 2006;25(5):945–57.

Van Doorslaer E, Wagstaff A. Equity in the finance of health care: Some international comparisons. J Health Econ. 1992;11(4):361–87.

Deb P, Norton EC, Manning WG. Health Econometrics Using Stata. College Station, TX: Stata Press; 2017.

Wagstaff A, O’Donnell O, Van Doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington, DC: World Bank Publications; 2007.

Xio XX. Determinants and equity evaluation for health expenditure among patients with rare diseases in China. Chin Med J. 2016;129(12):1387–93.

Yoon TH. Inequalities in medical care utilization by South Korean cancer patients according to income: a retrospective cohort study. Int J Health Serv. 2011;41(1):51–66.

Kim CW, Lee SY, Hong SC. Equity in utilization of cancer inpatient services by income classes. Health Policy. 2005;72(2):187–200.

Kakwani NC. Income Inequality and Poverty: Methods of Estimation and Policy Applications. New York: Oxford University Press; 1980.

Korea Disease Control and Prevention Agency. Analyzing the status of rare diseases and ways to improve support for rare diseases patients in Korea. Wonju: Government Printing Office; 2019.

Macinko J, Lima-Costa MF. Horizontal equity in health care utilization in Brazil, 1998–2008. Int J Equity Health. 2012;11:33.

Choi EK. Cardiovascular research using the Korean national health information database. Korean Circ J. 2020;50(9):754–72.

Kim JA, Yoon SJ, Kim LY, Kim DS. Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data. J Korean Med Sci. 2017;32(5):718–28.

Anderen RM, Neuman J. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q. 1973;51(1):95–124.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả